Breaking News Instant updates and real-time market news.

MSFT

Microsoft

$139.68 /

-0.8 (-0.57%)

07:58
10/18/19
10/18
07:58
10/18/19
07:58

Microsoft assumed with an Outperform at RBC Capital

RBC Capital analyst Alex Zukin assumed coverage of Microsoft with an Outperform rating with a price target of $160, up from $153. The analyst believes that the company is "best positioned to outperform" over the next several years as it becomes a "strategic partner" to digital transformations among large enterprises, with mission-critical capabilities of its key portfolio assets - Azure and Office365. Zukin adds that Microsoft's Q1 revenue and earnings should see a "typical" period of outperformance, as he raises his FY20 EPS view by 6c to $5.21 and sees expectations of a 55% Azure growth next year as "reasonable".

  • 18

    Oct

  • 23

    Oct

  • 26

    Oct

  • 27

    Oct

  • 29

    Oct

  • 06

    Nov

MSFT Microsoft
$139.68 /

-0.8 (-0.57%)

10/16/19 William Blair
Slack overhang from Microsoft competition should dissipate, says William Blair
10/10/19 Wedbush
Wedbush expects Microsoft to post 'solid beat across the board'
10/09/19 DA Davidson
Slack Technologies price target lowered to $26 from $31 at DA Davidson
10/09/19 Morgan Stanley
CIOs see continued pressure on IT budgets in 2020, says Morgan Stanley

TODAY'S FREE FLY STORIES

General news
Kudlow says long-term investors should take 'serious look' at stock market here » 13:47
02/25/20
02/25
13:47
02/25/20
13:47
SPY

SPDR S&P 500 ETF Trust

$316.19 /

-6.24 (-1.94%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

The stock market is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Ally Financial call volume above normal and directionally bullish » 13:45
02/25/20
02/25
13:45
02/25/20
13:45
ALLY

Ally Financial

$26.34 /

-1.07 (-3.90%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
Kudlow says 'not hearing' about any emergency rate cut from Fed » 13:44
02/25/20
02/25
13:44
02/25/20
13:44
SPY

SPDR S&P 500 ETF Trust

$316.70 /

-5.73 (-1.78%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

Larry Kudlow, asked about…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
U.S. health leaders doing 'exactly what they should be doing,' Kudlow says » 13:39
02/25/20
02/25
13:39
02/25/20
13:39
SPY

SPDR S&P 500 ETF Trust

$316.55 /

-5.885 (-1.83%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

National Economic Council…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Wolfe Research tech strategist to hold an analyst/industry webcast » 13:36
02/25/20
02/25
13:36
02/25/20
13:36
AAPL

Apple

$294.22 /

-3.94 (-1.32%)

Tech Strategist…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
Kudlow says 'not at all convinced' U.S. can't get hold of what it needs » 13:36
02/25/20
02/25
13:36
02/25/20
13:36
SPY

SPDR S&P 500 ETF Trust

$316.46 /

-5.97 (-1.85%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

Speaking about the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
FHFA Director says Fannie, Freddie sahreholders will be 'heavily diluted' » 13:36
02/25/20
02/25
13:36
02/25/20
13:36
FNMA

Fannie Mae

$0.00 /

+ (+0.00%)

, FMCC

Freddie Mac

$0.00 /

+ (+0.00%)

Federal Housing Finance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
BTIG healthcare analysts to hold an analyst/industry conference call » 13:35
02/25/20
02/25
13:35
02/25/20
13:35
STAA

Staar Surgical

$30.52 /

-1.06 (-3.36%)

Healthcare Analysts,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Hilton put volume heavy and directionally bearish » 13:35
02/25/20
02/25
13:35
02/25/20
13:35
HLT

Hilton

$100.57 /

-3.445 (-3.31%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
Kudlow says U.S. has contained coronavirus 'pretty close to airtight' » 13:34
02/25/20
02/25
13:34
02/25/20
13:34
SPY

SPDR S&P 500 ETF Trust

$316.44 /

-5.99 (-1.86%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

Kudlow says, while a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
FX Action: EUR-USD » 13:30
02/25/20
02/25
13:30
02/25/20
13:30

FX Action: EUR-USD…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
Treasury $40 B 2-year auction stats were relatively disappointing » 13:30
02/25/20
02/25
13:30
02/25/20
13:30

Treasury $40 B 2-year…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Wedbush pharma/biotech analysts to hold an analyst/industry conference call » 13:29
02/25/20
02/25
13:29
02/25/20
13:29

Emerging Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Options
Zynga call volume above normal and directionally bullish » 13:25
02/25/20
02/25
13:25
02/25/20
13:25
ZNGA

Zynga

$7.03 /

+0.005 (+0.07%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
House Energy & Commerce Committee to hold a hearing » 13:25
02/25/20
02/25
13:25
02/25/20
13:25

The Health Subcommittee…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
FDANews to hold a webinar » 13:25
02/25/20
02/25
13:25
02/25/20
13:25

Jennifer Diaz, an expert…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Wolfe Research tech strategist to hold an analyst/industry webcast » 13:25
02/25/20
02/25
13:25
02/25/20
13:25

Tech Strategist…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Iovance trading resumes, shares up 19% $29.41 after Bloomberg report  13:24
02/25/20
02/25
13:24
02/25/20
13:24
IOVA

Iovance Biotherapeutics

$24.75 /

+0.06 (+0.24%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Norwegian Cruise Line participates in a conference call with Wedbush » 13:23
02/25/20
02/25
13:23
02/25/20
13:23
NCLH

Norwegian Cruise Line

$40.32 /

-2.3 (-5.40%)

Leisure Analyst Hardiman…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Iovance Biotherapeutics trading resumes  13:22
02/25/20
02/25
13:22
02/25/20
13:22
IOVA

Iovance Biotherapeutics

$24.68 /

-0.01 (-0.04%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Iovance Biotherapeutics jumps 11% after Bloomberg says exploring sale » 13:21
02/25/20
02/25
13:21
02/25/20
13:21
IOVA

Iovance Biotherapeutics

$24.68 /

-0.01 (-0.04%)

Shares of Iovance…

Shares of Iovance Biotherapeutics jumped, then halted for volatility, after Ed Hammond and Nabila Ahmed of Bloomberg reported that the company is exploring a sale and has held preliminary talks with potential buyers. Iovance is working with a financial adviser after receiving takeover interest, a source told Bloomberg. Iovance shares jumped 11%, or $2.63, to $27.32 following the report, triggering a halt for volatility.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Iovance Biotherapeutics exploring potential sale, Bloomberg reports  13:18
02/25/20
02/25
13:18
02/25/20
13:18
IOVA

Iovance Biotherapeutics

$24.68 /

-0.01 (-0.04%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Iovance Biotherapeutics trading halted, volatility trading pause  13:17
02/25/20
02/25
13:17
02/25/20
13:17
IOVA

Iovance Biotherapeutics

$24.61 /

-0.08 (-0.32%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Technical Analysis
NASDAQ market internals summary » 13:17
02/25/20
02/25
13:17
02/25/20
13:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Technical Analysis
NYSE market internals summary » 13:16
02/25/20
02/25
13:16
02/25/20
13:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.